Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus

NCT06098625 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus
Kidney Transplant; Complications

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Linagliptin 5 mg Oral Tablet

Sponsor

Medanta, The Medicity, India